Skip to content

NAGE NAGE Pharmaceuticals segment — Advertising

Other segment segments

Consumer Products segment
$3.29M+10.6%
Analytical Reference Standards and Services segment
$0
Ingredients segment
$0

Similar metrics at other companies

AMP
AMPHPharmaceutical Products — Marketing And Advertising Expense
$3.06M-21.3%
Valvoline logo
VVVReportable Segment — Advertising
$21.1M+20.6%
Syndax Pharmaceuticals logo
SNDXBiopharmaceutical Cancer Therapeutics — Marketing And Advertising Expense
$7.72M-28.7%
Grove Collaborative Holdings logo
GROVReportable Segment — Advertising
$1.16M-58.6%
CNB Financial logo
CCNEReportable Segment — Advertising
$788K+53.3%
BellRing Brands logo
BRBRReportable Segment — Advertising expenses
$36.3M+31.5%

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:AdvertisingExpense.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's pharmaceuticals segment — advertising.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's pharmaceuticals segment — advertising?
NAGE (NAGE) reported pharmaceuticals segment — advertising of $0 in Q1 2026.
What does pharmaceuticals segment — advertising mean?
Reflects the expenditures dedicated to promotional campaigns and media placements aimed at increasing brand awareness for pharmaceutical products. This investment is intended to drive future sales and market penetration. Analyzing this spend helps determine the segment's commitment to commercial growth and customer acquisition.